Model
Edge
CorMedix Inc
CRMD
Filing Type
8-K
Filing Date
8/6/2025
Updated
8/7/25, 5:31 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Financial Results, Unregistered Sales of Equity Securities, Reg. FD, Other Events
EX-2.1
AGREEMENT AND PLAN OF MERGER, DATED AS OF AUGUST 7, 2025, BY AND AMONG CORMEDIX INC., MELINTA THERAPEUTICS, LLC, CORIANDER BIDCO LLC AND DEERFIELD PRIVATE DESIGN FUND IV, L.P., SOLELY IN ITS CAPACITY AS REPRESENTATIVE, AGENT AND ATTORNEY-IN-FACT
EX-4.1
FORM OF INDENTURE, TO BE ENTERED INTO BY AND BETWEEN CORMEDIX INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
EX-99.1
Material Contracts, Financial Results, Unregistered Sales of Equity Securities, Reg. FD, Other Events
EX-99.2
Material Contracts, Financial Results, Unregistered Sales of Equity Securities, Reg. FD, Other Events
EX-99.3
Material Contracts, Financial Results, Unregistered Sales of Equity Securities, Reg. FD, Other Events
EX-99.4
Material Contracts, Financial Results, Unregistered Sales of Equity Securities, Reg. FD, Other Events
EX-99.5
Material Contracts, Financial Results, Unregistered Sales of Equity Securities, Reg. FD, Other Events
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic